Hello, Fool! | Login | Signup | My Fool
Oct 12, 2008 9:01 PM ET | Feedback | Site Changes | Help
A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.
View All Commentary (MNTA)
Recs
jphirsch (58.82) Submitted: 4/17/07 10:31 PM : Start Price: $15.42 MNTA Score: 1.30
Was brought down by a legal decision which was actually somewhat in their favor. Additionally, waiting on FDA ruling, which could seriously boost the stock. Finally, if that fails - then they are developing new drugs in addition with this same proprietary technology.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK